Page last updated: 2024-11-02

oxybutynin and Hypoglycemia

oxybutynin has been researched along with Hypoglycemia in 6 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Hypoglycemia: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.

Research Excerpts

ExcerptRelevanceReference
"A microdevice that offers glucagon supplements in a safe, non-invasive, and glucose-responsive manner is ideal for avoiding fatal hypoglycemia consequences from insulin overdosage during daily diabetes treatment."4.12Shrinking Fabrication of a Glucose-Responsive Glucagon Microneedle Patch. ( Fu, R; Gu, Z; Han, X; Li, S; Wang, Z; Wen, D; Wu, Y, 2022)
"Hypoglycemia is a serious and potentially fatal complication experienced by people with insulin-dependent diabetes."1.72Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention. ( GhavamiNejad, A; Giacca, A; Liu, JF; Lu, B; Mirzaie, S; Pereira, S; Samarikhalaj, M; Wu, XY; Zhou, L, 2022)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Schlozman, SC1
Hennessey, JV1
Wang, Z1
Fu, R1
Han, X1
Wen, D1
Wu, Y1
Li, S1
Gu, Z2
GhavamiNejad, A2
Lu, B2
Samarikhalaj, M1
Liu, JF1
Mirzaie, S1
Pereira, S1
Zhou, L2
Giacca, A2
Wu, XY2
Wynn, P1
Li, J1
Lam, L1
Hu, X1
Yu, J1
Qian, C1
Lu, Y1
Kahkoska, AR1
Xie, Z1
Jing, X1
Buse, JB1

Other Studies

6 other studies available for oxybutynin and Hypoglycemia

ArticleYear
Mechanical misadministration of an oral hypoglycemic agent.
    Diabetes care, 1997, Volume: 20, Issue:11

    Topics: Administration, Oral; Aged; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Mandelic Aci

1997
Shrinking Fabrication of a Glucose-Responsive Glucagon Microneedle Patch.
    Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022, Volume: 9, Issue:28

    Topics: Animals; Biocompatible Materials; Diabetes Mellitus; Glucagon; Glucose; Hypoglycemia; Insulin; Mice;

2022
Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention.
    Drug delivery and translational research, 2022, Volume: 12, Issue:4

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Delivery Sy

2022
NEW FOR YOU! These innovative products aim to help make diabetes self-management easier.
    Diabetes self-management, 2017, Volume: 34, Issue:2

    Topics: Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus; Drug Combinations; Glucose; Humans;

2017
Glucose-Responsive Composite Microneedle Patch for Hypoglycemia-Triggered Delivery of Native Glucagon.
    Advanced materials (Deerfield Beach, Fla.), 2019, Volume: 31, Issue:30

    Topics: Animals; Blood Glucose; Cross-Linking Reagents; Diabetes Mellitus, Experimental; Diabetes Mellitus,

2019
H
    ACS nano, 2017, 01-24, Volume: 11, Issue:1

    Topics: Animals; Diabetes Mellitus, Experimental; Drug Carriers; Drug Delivery Systems; Glucose; Glucose Oxi

2017